Assessment of the palatability of elemental nutritional supplements compared to non-elemental supplements in people with pelvic cancers and people without cancer, and whether this changes following treatment with radiotherapy

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

ISRCTN

Registry ID

ISRCTN35391431

Enrollment

Registered

2005-11-21

Start date

2004-01-26

Completion date

Unknown

Last updated

2015-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pelvic (gynaecological, urological or rectal) cancers Cancer Pelvic

Interventions

Subjects were randomised to one of five groups. Each group was assigned a target quantity of 3 different elemental sip feeds (Group 1, 20%, Group 2, 50%, Group 3, 75% of calorie requirements taken as

Group 4, 50% of calorie requirements taken as E028 extra powder

Group 5, 50% of calorie requirements taken as Emsogen powder).

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients about to embark on a course of radical pelvic radiotherapy for pelvic malignancy

Exclusion criteria

Exclusion criteria: 1. Unwilling or unable to give informed consent to participate in the study 2. A clinical condition precluding oral feeding (e.g. dysphagia, bowel obstruction) 3. Unable to tolerate milk 4. Controls with a previous history of pelvic malignancy or currently receiving chemotherapy or radiotherapy

Design outcomes

Primary

Measure	Time frame
Taste assessed by visual analogue scale	—

Secondary

Measure	Time frame
Not provided at time of registration	—

Countries

United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026